Viewing Study NCT05148195


Ignite Creation Date: 2025-12-24 @ 1:17 PM
Ignite Modification Date: 2025-12-27 @ 4:15 PM
Study NCT ID: NCT05148195
Status: TERMINATED
Last Update Posted: 2024-03-13
First Post: 2021-11-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module